Related references
Note: Only part of the references are listed.Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade
Matthew J. Sanders et al.
BIOCHEMICAL JOURNAL (2007)
AMP-activated protein kinase mediates VEGF-stimulated endothelial NO production
James A. Reihill et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Thrombin activates AMP-activated protein kinase in endothelial cells via a pathway involving Ca2+/calmodulin-dependent protein kinase kinase β
Nadine Stahmann et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Antiangiogenic effect of rosiglitazone is mediated via peroxisome proliferator-activated receptor γ-activated maxi-K channel opening in human umbilical vein endothelial cells
KY Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
PPARγ and human metabolic disease
RK Semple et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers
J Hetzel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
A novel thiazolidinedione MCC-555 down-regulates tumor necrosis factor-α-induced expression of vascular cell adhesion molecule-1 in vascular endothelial cells
S Kurebayashi et al.
ATHEROSCLEROSIS (2005)
Peroxisome proliferator-activated receptor γ ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor γ-dependent mechanisms
JA Polikandriotis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Ca2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells
A Woods et al.
CELL METABOLISM (2005)
Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase
SA Hawley et al.
CELL METABOLISM (2005)
Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction
K Sakamoto et al.
EMBO JOURNAL (2005)
Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells
D Konrad et al.
DIABETOLOGIA (2005)
Myocardial ischemia differentially regulates LKB1 and an alternate 5′-AMP-activated protein kinase kinase
JY Altarejos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1
JM Lizcano et al.
EMBO JOURNAL (2004)
Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo
AK Saha et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome
TD Wang et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control
F Pistrosch et al.
DIABETES CARE (2004)
Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone -: Evidence for involvement of peroxisome proliferator-activated receptor (PPAR)γ-dependent and PPARγ-independent signaling pathways
DH Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Calcineurin is required for translational control of protein synthesis in rat pancreatic acini
MD Sans et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Vascular effects of improving metabolic control with melformin or rosiglitazone in type 2 diabetes
A Natali et al.
DIABETES CARE (2004)
Simple and extractionless high-performance liquid chromatographic determination of rosiglitazone in human plasma and application to pharmacokinetics in humans
KA Kim et al.
BIOMEDICAL CHROMATOGRAPHY (2004)
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade
A Woods et al.
CURRENT BIOLOGY (2003)
Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of L-arginine metabolism to efficient nitric oxide production
MI Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect
N Satoh et al.
DIABETES CARE (2003)
Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells
VA Morrow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells
DS Calnek et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Ionizing radiation induces ataxia telangiectasia mutated kinase (ATM)-mediated phosphorylation of LKB1/STK11 at Thr-366
GP Sapkota et al.
BIOCHEMICAL JOURNAL (2002)
The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways
LGD Fryer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Protein kinase substrate recognition studied using the recombinant catalytic domain of AMP-activated protein kinase and a model substrate
JW Scott et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser1179
M Montagnani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Antioxidants, diabetes and endothelial dysfunction
DW Laight et al.
CARDIOVASCULAR RESEARCH (2000)
Share Paper
